News
A powerhouse partnership in family entertainment to reintroduce a timeless stop-motion classic to new audiences in Korea ...
Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results